IL142153A0 - Non-endogenous, constitutively activated human g protein-coupled receptors - Google Patents

Non-endogenous, constitutively activated human g protein-coupled receptors

Info

Publication number
IL142153A0
IL142153A0 IL14215399A IL14215399A IL142153A0 IL 142153 A0 IL142153 A0 IL 142153A0 IL 14215399 A IL14215399 A IL 14215399A IL 14215399 A IL14215399 A IL 14215399A IL 142153 A0 IL142153 A0 IL 142153A0
Authority
IL
Israel
Prior art keywords
endogenous
protein
coupled receptors
activated human
constitutively activated
Prior art date
Application number
IL14215399A
Original Assignee
Arena Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/170,496 external-priority patent/US6555339B1/en
Application filed by Arena Pharm Inc filed Critical Arena Pharm Inc
Publication of IL142153A0 publication Critical patent/IL142153A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL14215399A 1998-10-13 1999-10-13 Non-endogenous, constitutively activated human g protein-coupled receptors IL142153A0 (en)

Applications Claiming Priority (33)

Application Number Priority Date Filing Date Title
US09/170,496 US6555339B1 (en) 1997-04-14 1998-10-13 Non-endogenous, constitutively activated human protein-coupled receptors
US10802998P 1998-11-12 1998-11-12
US10921398P 1998-11-20 1998-11-20
US11006098P 1998-11-27 1998-11-27
US12041699P 1999-02-16 1999-02-16
US12185299P 1999-02-26 1999-02-26
US12394699P 1999-03-12 1999-03-12
US12394499P 1999-03-12 1999-03-12
US12395199P 1999-03-12 1999-03-12
US12394599P 1999-03-12 1999-03-12
US12394999P 1999-03-12 1999-03-12
US12394899P 1999-03-12 1999-03-12
US13643799P 1999-05-28 1999-05-28
US13713199P 1999-05-28 1999-05-28
US13656799P 1999-05-28 1999-05-28
US13643699P 1999-05-28 1999-05-28
US13712799P 1999-05-28 1999-05-28
US13643999P 1999-05-28 1999-05-28
US14144899P 1999-06-29 1999-06-29
US15111499P 1999-08-27 1999-08-27
US15252499P 1999-09-03 1999-09-03
US15663499P 1999-09-29 1999-09-29
US15663399P 1999-09-29 1999-09-29
US15665399P 1999-09-29 1999-09-29
US15655599P 1999-09-29 1999-09-29
US15728099P 1999-10-01 1999-10-01
US15728299P 1999-10-01 1999-10-01
US15728199P 1999-10-01 1999-10-01
US15729399P 1999-10-01 1999-10-01
US15729499P 1999-10-01 1999-10-01
US41676099A 1999-10-12 1999-10-12
US41704499A 1999-10-12 1999-10-12
PCT/US1999/024065 WO2000022131A2 (en) 1998-10-13 1999-10-13 Non-endogenous, constitutively activated human g protein-coupled receptors

Publications (1)

Publication Number Publication Date
IL142153A0 true IL142153A0 (en) 2002-03-10

Family

ID=27586908

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14215399A IL142153A0 (en) 1998-10-13 1999-10-13 Non-endogenous, constitutively activated human g protein-coupled receptors

Country Status (5)

Country Link
KR (1) KR20010080882A (en)
CA (1) CA2348688A1 (en)
IL (1) IL142153A0 (en)
NZ (1) NZ510712A (en)
WO (1) WO2000022131A2 (en)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119190B2 (en) 1997-04-14 2006-10-10 Arena Pharmaceuticals, Inc. Endogenous and non-endogenous versions of human G protein-coupled receptors
US6555339B1 (en) 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
WO1999024569A1 (en) * 1997-11-11 1999-05-20 Ono Pharmaceutical Co., Ltd. Human lysophosphatidic acid receptor and use thereof
ES2300074T3 (en) 1998-03-12 2008-06-01 Astellas Pharma Inc. NEW PROTEINS OF RECEPTORS COPULATED TO PROTEINA G.
US7094593B1 (en) 1998-09-01 2006-08-22 Basf Aktiengesellschaft Method for improving the function of heterologous G protein-coupled receptors
JP2004500013A (en) * 1998-10-16 2004-01-08 ミレニアム・ファーマシューティカルズ・インコーポレイテッド Novel G protein-coupled receptor
WO2000026339A2 (en) * 1998-11-03 2000-05-11 Smithkline Beecham Corporation Axor14, a g-protein coupled receptor
US7816492B2 (en) 1998-11-20 2010-10-19 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors
KR20080104062A (en) * 1998-11-20 2008-11-28 아레나 파마슈티칼스, 인크. Human Orphan Ｇ Protein Coupling Receptors
US20030017528A1 (en) 1998-11-20 2003-01-23 Ruoping Chen Human orphan G protein-coupled receptors
USRE42190E1 (en) 1998-11-20 2011-03-01 Arena Pharmaceuticals, Inc. Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
US6221660B1 (en) 1999-02-22 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding SNORF25 receptor
EP1189944A4 (en) * 1999-06-21 2002-09-11 Smithkline Beecham Corp G-PROTEIN COUPLED RECEPTOR AXOR16
EP1198569A1 (en) * 1999-07-30 2002-04-24 MERCK PATENT GmbH G-protein coupled receptor and dna sequences thereof
CA2391868A1 (en) * 1999-08-27 2001-03-08 Takeda Chemical Industries, Ltd. Novel g protein-coupled receptor protein and dna thereof
AU6727800A (en) * 1999-08-27 2001-03-26 Takeda Chemical Industries Ltd. Novel g protein-coupled receptor protein and dna thereof
JP2003225088A (en) * 1999-09-10 2003-08-12 Meiji Seika Kaisha Ltd Human leukotriene B4 second receptor and DNA encoding the same
WO2001025269A2 (en) * 1999-09-24 2001-04-12 Solvay Pharmaceuticals B.V. Human g-protein coupled receptor
US6998255B1 (en) 1999-09-24 2006-02-14 Solvay Pharmaceuticals B.V. Human G-protein coupled receptor
GB9923177D0 (en) * 1999-09-30 1999-12-01 Pfizer Ltd Novel polypeptide
GB9923893D0 (en) * 1999-10-08 1999-12-08 Pfizer Ltd Novel polypeptide
GB9923890D0 (en) * 1999-10-08 1999-12-08 Pfizer Ltd Novel polypeptide
GB9923888D0 (en) 1999-10-08 1999-12-08 Pfizer Ltd Novel polypeptide
GB9924960D0 (en) * 1999-10-21 1999-12-22 Pfizer Ltd Novel polypeptide
CA2386509A1 (en) * 1999-10-27 2001-05-03 Pharmacia & Upjohn Company G protein-coupled receptors expressed in human brain
ATE375390T1 (en) * 1999-10-29 2007-10-15 Pfizer G-PROTEIN-COUPLED RECEPTOR-LIKE PROTEINS
WO2001032865A1 (en) * 1999-11-03 2001-05-10 Merck Patent Gmbh Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences
AU784543B2 (en) * 1999-11-16 2006-04-27 Pharmacia & Upjohn Company Novel G protein-coupled receptors
NZ531722A (en) * 1999-11-17 2006-06-30 Arena Pharm Inc Endogenous and non-endogenous versions of human G protein-coupled receptors
US7029857B1 (en) 1999-12-17 2006-04-18 H. Lundbeck A/S Processes for obtaining compounds employing SNORF72 receptors
WO2001046414A1 (en) * 1999-12-20 2001-06-28 Banyu Pharmaceutical Co., Ltd. Novel guanosine triphosphate-binding protein-coupled receptor protein, bg26
AU2288601A (en) 1999-12-23 2001-07-03 Millennium Pharmaceuticals, Inc. P2Y12 receptor
GB0001700D0 (en) * 2000-01-25 2000-03-15 Glaxo Group Ltd Novel protein
AU3222701A (en) 2000-02-04 2001-08-14 Takeda Chemical Industries Ltd. Screening method
ATE356208T1 (en) * 2000-03-14 2007-03-15 Bayer Healthcare Ag REGULATION OF HUMAN LIPOXIN A4 RECEPTOR-LIKE PROTEIN
AU3930201A (en) * 2000-03-17 2001-09-24 Bayer Aktiengesellschaft Regulation of human leukotriene B4-like G protein-coupled receptor
US20030077709A1 (en) * 2000-03-21 2003-04-24 Masazumi Kamohara Novel leukotriene B4 receptor
WO2001073021A1 (en) * 2000-03-28 2001-10-04 Takeda Chemical Industries, Ltd. Novel g protein-coupled receptor protein and dna thereof
WO2001073023A1 (en) * 2000-03-31 2001-10-04 Helix Research Institute Novel guanosine triphosphate-binding protein-coupled receptor gprv53, gene thereof and production and use of the same
WO2001077326A1 (en) * 2000-04-12 2001-10-18 Takeda Chemical Industries, Ltd. Novel g protein-coupled receptor protein and dna thereof
EP1178110A1 (en) * 2000-08-01 2002-02-06 Aventis Pharma Deutschland GmbH EDG8 receptor for sphingosine 1-phosphate , its preparation and use
US7163799B2 (en) 2000-04-27 2007-01-16 Merck & Co., Inc. Neuromedin U receptor NMUR2 and nucleotides encoding it
AU2001259513A1 (en) * 2000-05-05 2001-11-20 Wyeth Human histamine h4 receptor
EP1282645A2 (en) * 2000-05-08 2003-02-12 PHARMACIA & UPJOHN COMPANY G protein-coupled receptors
US20030148451A1 (en) * 2000-05-09 2003-08-07 Kevin Bacon Endothelial differntiation gene 6-like g protein coupled receptor
AU2001269013A1 (en) * 2000-05-18 2001-11-26 Bayer Aktiengesellschaft Human galanin receptor-like g protein coupled receptor
ATE348162T1 (en) * 2000-05-18 2007-01-15 Bayer Healthcare Ag REGULATION OF A HUMAN DOPAMINE-LIKE G-PROTEIN COUPLED RECEPTOR.
CA2408134A1 (en) * 2000-05-18 2001-11-22 Incyte Genomics, Inc. G-protein coupled receptors
CA2410734A1 (en) 2000-05-31 2001-12-06 Ortho-Mcneil Pharmaceutical, Inc. Dnas encoding mammalian histamine receptor of the h4 subtype
AU2001276837A1 (en) * 2000-06-23 2002-01-08 Tularik, Inc. Human and mouse g-protein couipled receptors
AU2001281933A1 (en) * 2000-06-30 2002-01-14 Ingenium Pharmaceuticals Ag Human g protein-coupled receptor igpcr17, and uses therof
US6927041B2 (en) 2000-07-06 2005-08-09 Bayer Corporation Human neuropeptide Y-like G protein-coupled receptor
US7462457B2 (en) * 2000-08-30 2008-12-09 Johns Hopkins University School Of Medicine Identification of activated receptors and ion channels
AU2000276780A1 (en) * 2000-10-02 2001-04-23 Biofocus Discovery Limited Cellular receptor mutations predicted by multiple-sequence-allignment
DE60127435T2 (en) * 2000-11-01 2007-11-29 Astellas Pharma Inc. METHOD FOR SCREENING A PLATFORM HEMMERS
CA2426037A1 (en) * 2000-11-07 2002-05-16 Paradigm Therapeutics Limited A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
DE60125227T2 (en) 2000-12-01 2007-09-20 Astellas Pharma Inc. METHOD FOR SCREENING DIABETES HEALING METHODS
AU2002222681A1 (en) * 2000-12-19 2002-07-01 Takeda Chemical Industries Ltd. Novel transmembrane receptor-like proteins and dnas thereof
US7157244B2 (en) 2001-01-17 2007-01-02 Schering Corporation Adenosine receptor
WO2002088355A1 (en) * 2001-04-25 2002-11-07 Fujisawa Pharmaceutical Co., Ltd. Novel guanosine triphosphate-binding protein-coupled recepotr place 6002312 and its gene and production and use of the same
US6919176B2 (en) 2001-05-07 2005-07-19 Amgen Inc. Polypeptides and nucleic acids associated with cancer
AU2002310326A1 (en) * 2001-06-05 2002-12-23 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated versions of plant g protein-coupled receptor: gcr1
US6902902B2 (en) 2001-11-27 2005-06-07 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders
WO2003087134A2 (en) 2002-04-12 2003-10-23 Schering Corporation G-protein coupled receptor ligands and methods
WO2003102159A2 (en) * 2002-06-04 2003-12-11 Curagen Corporation Novel proteins and nucleic acids encoding same
WO2004022086A1 (en) * 2002-09-02 2004-03-18 Takeda Pharmaceutical Company Limited Adrenocortical hormone secretion controller
WO2004033687A1 (en) * 2002-10-11 2004-04-22 Yamanouchi Pharmaceutical Co., Ltd. Method of screening remedy for renal failure
US7056685B1 (en) 2002-11-05 2006-06-06 Amgen Inc. Receptor ligands and methods of modulating receptors
WO2004060282A2 (en) * 2002-12-19 2004-07-22 Synaptic Pharmaceutical Corporation Uses of the snorf207 receptor
US7083933B1 (en) 2003-05-09 2006-08-01 Prosidion Limited Methods for identification of modulators of OSGPR116 activity
US8791100B2 (en) 2010-02-02 2014-07-29 Novartis Ag Aryl benzylamine compounds
EP3538550A1 (en) 2016-11-10 2019-09-18 Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts Or10h1 modulators and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4442930B2 (en) * 1995-12-11 2010-03-31 タフツ メディカル センター インコーポレイテッド Assay methods for peptide hormone receptor ligands and uses thereof
US6255089B1 (en) * 1997-02-27 2001-07-03 Albany Medical College Constitutively activated serotonin receptors
WO1999024569A1 (en) * 1997-11-11 1999-05-20 Ono Pharmaceutical Co., Ltd. Human lysophosphatidic acid receptor and use thereof

Also Published As

Publication number Publication date
WO2000022131A3 (en) 2001-02-22
CA2348688A1 (en) 2000-04-20
NZ510712A (en) 2004-11-26
KR20010080882A (en) 2001-08-25
WO2000022131A2 (en) 2000-04-20

Similar Documents

Publication Publication Date Title
IL142153A0 (en) Non-endogenous, constitutively activated human g protein-coupled receptors
IL152136A0 (en) Non-endogenous, constitutively activated known g protein-coupled receptors
IL149111A0 (en) Small molecule modulators of non-endogenous, constitutively activated human serotonin receptors
PL352232A1 (en) Il-8 receptor antagonists
IL146151A0 (en) Human-g-protein receptor
IL145762A0 (en) Il-8 receptor antagonists
IL146046A0 (en) Il-8 receptor antagonists
AU2001240097A1 (en) G protein-coupled receptors
ZA200109627B (en) IL-8 receptor antagonists.
EP1183386A4 (en) Tm4sf receptors
AU2001249922A1 (en) G protein-coupled receptors
IL142362A0 (en) Ureidopiperidine derivatives as selective human nk3 receptor antagonists
AU2574801A (en) Selective iGLUR5 receptor antagonists
EP1194143A4 (en) Il-8 receptor antagonists
HK1042511A1 (en) Non-endogenous, constitutively activated human g protein-coupled receptors
AU2001259322A1 (en) G protein-coupled receptors
AU2001238682A1 (en) Human g protein-coupled receptors
EP1100813A4 (en) HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb
EP1185270A4 (en) Il-8 receptor antagonists
AU4551401A (en) Novel g protein-coupled receptors
AU4992301A (en) Novel g protein-coupled receptors
AU2001263346A1 (en) G protein-coupled receptors
AU5961201A (en) Novel g protein-coupled receptors
IL160446A0 (en) Endogenous constitutively activated g protein-coupled orphan receptors
ZA200110203B (en) IL-8 receptor antagonists.